"Smart pills" at a low start
Frost & Sullivan: the boom in the market of "smart tablets" will occur in 2018-2020.
The evolution of technologies in the field of minimally invasive and remotely controlled devices will contribute to the growth of this market.
The growing need for convenient diagnostic tools and high-precision therapeutic techniques contributes to the evolution in the field of "smart tablets". In some areas, such as diagnostic imaging, smart pill technologies have already been successfully commercialized – in others, such as drug delivery and surgery, they have yet to undergo clinical trials. In addition, there is a trend towards the widespread commercial use of wireless capsule endoscopes and swallowed sensors for monitoring internal organs.
The results of a new study by Frost & Sullivan "Innovations in Smart Pills" (Innovations in Smart Pills) indicate a clear trend towards minimally invasive and remotely controlled devices for diagnostics and therapeutic procedures. Smart tablets are widely used for diagnostic imaging of the gastrointestinal tract, replacing invasive endoscopy. The development of technologies used in such devices, such as wireless data transmission, remote monitoring of the condition of patients and miniaturization, will contribute to the wider use of "smart tablets".
Frost & Sullivan is an international consulting company that maintains partnerships with clients. The company's services contribute to the development of clients' business, as well as to achieving stable growth, constant innovation and maintaining leadership positions. The company's services – Growth Partnership Service – are based on detailed market research and the use of advanced research models and practices. Our products help partners develop, evaluate and implement strategic objectives and achieve their goals. For 50 years, Frost & Sullivan has been cooperating with companies from the Global 1000 list, young developing companies, as well as investment and financial organizations. Frost & Sullivan has 40 offices worldwide.
More detailed information can be found on the company's website.
"In the smart tablet industry, apparently, we should expect rapid development and release of new products over the next 5-7 years, which opens up the widest opportunities for cooperation between industrial and research organizations," said Frost & Sullivan, an analyst at the Department of Technological Research. – New developments of the participants in this industry can lead to the emergence of revolutionary products, such as capsule endoscopes, but only the use of the results of fundamental and applied research conducted at universities and research centers will help to achieve a qualitative breakthrough in this area."
Since this is an emerging market, it is extremely important to build confidence among all its participants: patients, doctors, researchers, investors and regulatory authorities. Such measures as strategic business partnership, scientific and medical education will help to gain the trust of the authorities, investors and users.
In addition, it is important that companies can take advantage of government funding programs for universities and small businesses. This is especially important in light of the unequal distribution of venture capital investments, as a result of which start-up companies cannot gain strength.
In addition, in recent years, the indicators of the value of companies have decreased. Partnership with laboratories that have access to funds for basic and applied research will help to enlist financial support that can be used to organize commercial production. Moreover, State-sponsored research projects have served as the basis for highly successful cooperation between research and industrial organizations. Such research consortia are especially common in the EU countries. As a result, successful commercial products and technologies are emerging that allow expanding the scope of "smart tablets".
"Small companies that cannot effectively commercialize technology can also license their developments to companies whose solutions are widely represented on the market," suggests the analyst, Frost & Sullivan. "At the same time, new players can rely on technology incubators to achieve commercial implementation of their developments."
Finally, leading players trying to expand the geography of their activities can enter into agreements with local companies engaged in the production of medical devices and use their experience, as well as already formed marketing networks. The most favorable markets for investment, especially for new players, are the countries of Europe and East Asia.
If you are interested in receiving additional information on this topic, send an email to Yulia Nikishkina, a specialist in the Frost & Sullivan Public Relations Department. In the message, please indicate your first name, last name, company name and contact information.
Yulia Nikishkina
Public Relations Department – Russia
Phone: +7 (499) 213 0156
Email: julia.nikishkina@frost.comPortal "Eternal youth" http://vechnayamolodost.ru